Long-acting basal insulin
This page covers all Long-acting basal insulin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor.
Targets
Marketed (17)
- Continuation of insulin glargine · Providence Health & Services · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake into cells and inhibiting hepatic glucose production. - Levemir (insulin detemir) · Rabin Medical Center · Diabetes
Insulin detemir is a long-acting basal insulin that binds to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in peripheral tissues while suppressing hepatic glucose production. - Insulin glargine (HOE901) · Sanofi · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and reduce blood glucose levels. - Insulin degludec, 100U/ml · Sanofi · Diabetes
Insulin degludec is a long-acting basal insulin that binds to the insulin receptor to promote glucose uptake and utilization in peripheral tissues while suppressing hepatic glucose production. - Toujeo SoloStar · Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud · Diabetes
Toujeo SoloStar is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake and storage in cells. - insulin glargine [rDNA origin] injection · Sanofi · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels. - Insulin glargine, 300U/mL · Sanofi · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and reduce blood glucose levels. - Insulin Glargine 100 UNT/ML · University Hospital Tuebingen · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and reduce blood glucose levels. - INSULIN GLARGINE HOE 901 · Sanofi · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and lower blood glucose levels. - Gla-100 (insulin glargine) · Sanofi · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and reduce blood glucose levels. - Insulin glargine, 100 U/ml · Sanofi · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and utilization while suppressing hepatic glucose production. - Insulin degludec 100 U/mL · Sanofi · Diabetes
Insulin degludec is a long-acting basal insulin that binds to the insulin receptor to promote glucose uptake and utilization in peripheral tissues while suppressing hepatic glucose production. - Insulin glargine U100 · Novo Nordisk A/S · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and reduce blood glucose levels. - Insulin glargine 300 U/ml · Sanofi · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels. - Insulin glargine (U300) · Sanofi · Diabetes
Insulin glargine (U300) is a long-acting basal insulin that binds to insulin receptors on muscle and fat cells to promote glucose uptake and reduce blood glucose levels. - biosimilar insulin glargine · Life for a Child Program, Diabetes Australia · Diabetes
Biosimilar insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and lower blood glucose levels. - IGlar U100 · Novo Nordisk A/S · Diabetes
IGlar U100 is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake and storage in peripheral tissues.
Phase 3 pipeline (6)
- Insulin Glargine Rescue Medication · Merck Sharp & Dohme LLC · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake and storage in peripheral tissues while suppressing hepatic glucose production. - Gan & Lee Insulin Glargine Injection · Gan and Lee Pharmaceuticals, USA · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake and storage in peripheral tissues and suppressing hepatic glucose production. - Lantus (insulin glargine) · Sanofi · Diabetes
Lantus is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake into cells and inhibiting hepatic glucose production. - Insulin glargine U100 (HOE901) · Sanofi · Diabetes
Insulin glargine is a long-acting basal insulin that binds to the insulin receptor to promote glucose uptake and utilization in peripheral tissues while suppressing hepatic glucose production. - Lantus (glargine) · Massachusetts General Hospital · Diabetes
Lantus is a long-acting basal insulin that binds to insulin receptors to lower blood glucose by promoting glucose uptake and storage in cells. - Insulin Glargine 100U/mL · Novo Nordisk A/S · Diabetes
Insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and reduce blood glucose levels.